Celebrex No More Effective Than Older Drugs
at Reducing the Risk of Recurrent Ulcer Bleeding





photo-16

A recent study conducted by researchers at the Prince of Wales Hospital in Hong Kong concluded that Celebrex (celecoxib), one of the nation's top-selling arthritis drugs, may not be more effective than older anti-inflammatory drugs at reducing the risk of recurrent ulcer bleeding in patients with arthritis.

The findings of the study entitled "Celecoxib Versus Diclofenac and Omeprazole in Reducing the Risk of Recurrent Ulcer Bleeding in Patients with Arthritis" were published in the Dec. 26 issue of The New England Journal of Medicine.

The six-month study consisted of 287 patients who had previously suffered from bleeding …






UPCOMING CONFERENCES




HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

January 10, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS



HarrisMartin's MDL Conference

December 04, 2024 - New York, NY
Virgin Hotels NYC

MORE DETAILS